Very recently, it was demonstrated that LDH-A was essential for cancer-initiating cell proliferation and could be a feasible therapeutic target for non-small cell carcinoma (NSCLC) treatment in mouse models [22]. Here, LDHA is linked to non-small cell lung carcinoma.